| 36786841 | Correction to: Amplification of the PLAG-family genes-PLAGL1 and PLAGL2-is a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplification. | Acta Neuropathol | 2023 |
| 36240479 | Genomic Microsatellite Signatures Identify Germline Mismatch Repair Deficiency and Risk of Cancer Onset. | J Clin Oncol | 2023 |
| 36437415 | Amplification of the PLAG-family genes-PLAGL1 and PLAGL2-is a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplification. | Acta Neuropathol | 2023 |
| 36964296 | Pediatric-type high-grade neuroepithelial tumors with CIC gene fusion share a common DNA methylation signature. | NPJ Precis Oncol | 2023 |
| 34992263 | Genomic predictors of response to PD-1 inhibition in children with germline DNA replication repair deficiency. | Nat Med | 2022 |
| 35945463 | Multiplatform molecular analyses refine classification of gliomas arising in patients with neurofibromatosis type 1. | Acta Neuropathol | 2022 |
| 35814456 | An Integrated Analysis of Clinical, Genomic, and Imaging Features Reveals Predictors of Neurocognitive Outcomes in a Longitudinal Cohort of Pediatric Cancer Survivors, Enriched with CNS Tumors (Rad ART Pro). | Front Oncol | 2022 |
| 36201019 | Molecular and clinicopathologic characteristics of gliomas with EP300::BCOR fusions. | Acta Neuropathol | 2022 |
| 34433654 | Deconvoluting Mechanisms of Acquired Resistance to RAF Inhibitors in BRAF[V600E]-Mutant Human Glioma. | Clin Cancer Res | 2021 |
| 33945292 | Survival Benefit for Individuals With Constitutional Mismatch Repair Deficiency Undergoing Surveillance. | J Clin Oncol | 2021 |
| 33563663 | Mutations in the RAS/MAPK Pathway Drive Replication Repair-Deficient Hypermutated Tumors and Confer Sensitivity to MEK Inhibition. | Cancer Discov | 2021 |
| 31104347 | High-grade neuroepithelial tumor with BCOR exon 15 internal tandem duplication-a comprehensive clinical, radiographic, pathologic, and genomic analysis. | Brain Pathol | 2020 |
| 32303840 | Pediatric bithalamic gliomas have a distinct epigenetic signature and frequent EGFR exon 20 insertions resulting in potential sensitivity to targeted kinase inhibition. | Acta Neuropathol | 2020 |
| 32859279 | Comprehensive analysis of diverse low-grade neuroepithelial tumors with FGFR1 alterations reveals a distinct molecular signature of rosette-forming glioneuronal tumor. | Acta Neuropathol Commun | 2020 |
| 32895736 | Germline-driven replication repair-deficient high-grade gliomas exhibit unique hypomethylation patterns. | Acta Neuropathol | 2020 |
| 30877433 | Recurrent KBTBD4 small in-frame insertions and absence of DROSHA deletion or DICER1 mutation differentiate pineal parenchymal tumor of intermediate differentiation (PPTID) from pineoblastoma. | Acta Neuropathol | 2019 |
| 30608896 | Functional Repair Assay for the Diagnosis of Constitutional Mismatch Repair Deficiency From Non-Neoplastic Tissue. | J Clin Oncol | 2019 |
| 30196423 | The genetic landscape of gliomas arising after therapeutic radiation. | Acta Neuropathol | 2019 |
| 30417460 | Clinicopathologic features of anaplastic myxopapillary ependymomas. | Brain Pathol | 2019 |
| 31234291 | IGF1R Is a Potential New Therapeutic Target for HGNET-BCOR Brain Tumor Patients. | International Journal of Molecular Sciences | 2019 |
| 31515627 | Recurrent non-canonical histone H3 mutations in spinal cord diffuse gliomas. | Acta Neuropathol | 2019 |
| 29575995 | Large Vessel Arteriopathy After Cranial Radiation Therapy in Pediatric Brain Tumor Survivors. | J Child Neurol | 2018 |
| 29880043 | The genetic landscape of ganglioglioma. | Acta Neuropathol Commun | 2018 |
| 29753700 | Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort. | Lancet Oncol | 2018 |
| 29435664 | Deep sequencing of WNT-activated medulloblastomas reveals secondary SHH pathway activation. | Acta Neuropathol | 2018 |
| 27778212 | Survival after chemotherapy and stem cell transplant followed by delayed craniospinal irradiation is comparable to upfront craniospinal irradiation in pediatric embryonal brain tumor patients. | J Neurooncol | 2017 |
| 28453743 | Targeted next-generation sequencing of pediatric neuro-oncology patients improves diagnosis, identifies pathogenic germline mutations, and directs targeted therapy. | Neuro Oncol | 2017 |
| 29056344 | Comprehensive Analysis of Hypermutation in Human Cancer. | Cell | 2017 |
| 29371980 | Personalized therapy: CNS HGNET-BCOR responsiveness to arsenic trioxide combined with radiotherapy. | Oncotarget | 2017 |
| 27540084 | Presence of cerebral microbleeds is associated with worse executive function in pediatric brain tumor survivors. | Neuro Oncol | 2016 |
| 27161253 | IDH1 mutation can be present in diffuse astrocytomas and giant cell glioblastomas of young children under 10Â years of age. | Acta Neuropathol | 2016 |
| 26542077 | An infant with MLH3 variants, FOXG1-duplication and multiple, benign cranial and spinal tumors: A clinical exome sequencing study. | Genes Chromosomes Cancer | 2016 |
| 26238627 | Epithelioid Glioblastomas and Anaplastic Epithelioid Pleomorphic Xanthoastrocytomas--Same Entity or First Cousins? | Brain Pathol | 2016 |
| 23050818 | Use of the cardioprotectants thymosin β4 and dexrazoxane during congenital heart surgery: proposal for a randomized, double-blind, clinical trial. | Annals of the New York Academy of Sciences | 2012 |
| 19548852 | Antiangiogenic (metronomic) chemotherapy for brain tumors: current and future perspectives. | Expert Opin Investig Drugs | 2009 |
| 12060116 | Evidence that continued remission in patients treated for acute leukaemia is dependent upon autologous natural killer cells. | British Journal of Haematology | 2002 |
| 11417476 | Identification and molecular characterisation of a CALM-AF10 fusion in acute megakaryoblastic leukaemia. | Leukemia | 2001 |
| 9917751 | Hemihypertrophy and a poorly differentiated embryonal rhabdomyosarcoma of the pelvis. | Med Pediatr Oncol | 1999 |